Richard Ian Griffiths - 17 Apr 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Role
10%+ Owner
Signature
/s/ Richard Ian Griffiths
Issuer symbol
SLN
Transactions as of
17 Apr 2025
Net transactions value
$0
Form type
4
Filing time
22 Apr 2025, 10:35:32 UTC
Previous filing
15 Apr 2025
Next filing
24 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN American Depositary Shares Purchase +50,000 +0.5% 10,111,299 17 Apr 2025 Ordinary Shares 150,000 $3.14 Direct F1
transaction SLN American Depositary Shares Purchase +100,000 +0.99% 10,211,299 21 Apr 2025 Ordinary Shares 300,000 $3.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.